640. Resisting Resistance
Session: Named Lecture: Maxwell Finland Lecture: Resisting Resistance
Thursday, October 8, 2015: 5:00 PM
Room: 20--ABCD
Henry Chambers, MD, FIDSA, Clinical Research Services, University of California San Francisco, Clinical and Translational Sciences Institute, San Francisco, CA

Resume/CVs:


Disclosures:

H. Chambers, Cubist: Grant Investigator , Grant recipient
AstraZeneca: Scientific Advisor , Consulting fee
Pfizer: Scientific Advisor , Consulting fee
Theravance: Scientific Advisor , Consulting fee
Merck: Shareholder , Stock holder
Genentech: Investigator and Scientific Advisor , Consulting fee and Research grant

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.